Development of the PHASE-Proxy scale for rating drug-related signs and symptoms in severe cognitive impairment

Mariann HedströmDepartment of Public Health and Caring Sciences, Section of Caring Sciences, Uppsala University, Uppsala, SwedenCorrespondence[email protected]

http://orcid.org/0000-0001-6296-0160 View further author information

Marianne CarlssonDepartment of Public Health and Caring Sciences, Section of Caring Sciences, Uppsala University, Uppsala, Sweden;Department of Health and Caring Sciences, Faculty of Health and Occupational Studies, University of Gävle, Gävle, SwedenView further author information

Anna EkmanDepartment of medication and patient safety, Uppsala University Hospital, Uppsala, SwedenView further author information

Ulrika GillespieDepartment of medication and patient safety, Uppsala University Hospital, Uppsala, SwedenView further author information

Christina MörkPharmaceutical Committee, Uppsala County Council, Uppsala, SwedenView further author information

Kerstin Hulter ÅsbergDepartment of Neuroscience, Uppsala University, Uppsala, SwedenView further author information

Development of the PHASE-Proxy scale for rating drug-related signs and symptoms in severe cognitive impairment

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Development of the PHASE-Proxy scale for rating drug-related signs and symptoms in severe cognitive impairment

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date